Clinical Trial Update: An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia [Phase 2]

View source ↗

Summary

This document reports an open-label Phase 2 trial of an omega-3 fatty acid supplement (o3mega+Joy) for Social Anxiety Disorder, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• o3mega+Joy (Omega-3 fatty acids)

Snippet

Sponsor: START Clinic for Mood and Anxiety Disorders | Conditions: Social Anxiety Disorder | Phase 2 | Status: COMPLETED